Vaithi Arumugaswami is an associate professor at the Department of Molecular and Medical Pharmacology in the David Geffen School of Medicine at UCLA. After received his Ph.D. on cancer-causing viruses from the University of Arkansas, Vaithi served as a faculty director of the Viral Vector Core at Cedars-Sinai Medical Center, Los Angeles. He and his team have been developing Zika virus-based oncolytic therapy targeting the brain cancer glioblastoma. His team is focusing on the research and regulatory path to evaluate this innovative cancer treatment approach in first-in-human clinical study.